Share This Page
Drug Price Trends for NDC 00113-0958
✉ Email this page to a colleague
Average Pharmacy Cost for 00113-0958
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| GS CHLD COUGH DM ER 30 MG/5 ML | 00113-0958-21 | 0.06550 | ML | 2025-12-17 |
| GS CHLD COUGH DM ER 30 MG/5 ML | 00113-0958-28 | 0.04942 | ML | 2025-12-17 |
| GS CHLD COUGH DM ER 30 MG/5 ML | 00113-0958-21 | 0.06494 | ML | 2025-11-19 |
| GS CHLD COUGH DM ER 30 MG/5 ML | 00113-0958-28 | 0.04924 | ML | 2025-11-19 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 00113-0958
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDY: 00113-0958
Introduction
The pharmaceutical landscape continually evolves, driven by innovation, regulatory shifts, and market demand. For stakeholders in the drug identified by NDC: 00113-0958, an in-depth market analysis coupled with comprehensive price projections is essential to inform strategic decisions, investment planning, and competitive positioning. This report synthesizes current market dynamics, competitive landscape, regulatory environment, and financial trends affecting this specific drug.
Drug Overview and Therapeutic Context
The National Drug Code (NDC) 00113-0958 corresponds to [Insert precise drug name, generic name, and therapeutic class], approved by the FDA in [insert year]. This medication is primarily indicated for [target condition], with an estimated patient population of [approximate patient count or demographic details]. Its utilization is driven by [clinical guidelines, prevalence data, and existing treatment paradigms].
The drug's efficacy, safety profile, and dosing regimen position it within [specific therapeutic niche], competing with [list primary competitors]. Its mechanism of action involves [brief description], and current indications include [list of approved uses].
Market Dynamics
Market Size and Growth
According to [sources: IQVIA, EvaluatePharma, or other authoritative databases], the global market for [therapy area] is projected to reach $X billion by [year], growing at a CAGR of X%. The US accounts for approximately X% of this market, with an estimated [number] patients currently receiving treatment.
The demand surge correlates with rising [disease prevalence, aging populations, new clinical guidelines, or off-label uses]. The release of [brand-name or generic drug] has influenced market share dynamics, often leading to pricing pressures and increased competition.
Competitive Landscape
Among direct competitors, key players include [list of companies, e.g., Pharma A, B, and C]. The entry of biosimilars or generics influences pricing and market share, especially post-patent expiry. For drugs with exclusivity periods, market penetration remains tightly controlled through [pricing strategies, formulary access, or reimbursement policies].
The drug’s competitive advantages include [notable efficacy, dosing frequency, safety profile, or novel formulation]. Barriers to entry involve [regulatory hurdles, manufacturing complexities, or patent litigation].
Regulatory Environment & Patent Landscape
The FDA’s current regulatory status for NDY: 00113-0958 indicates [approved, off-label, or pending] status, with patent protections extending until [year]. Recent legal disputes, patent litigations, or biosimilar approvals may impact future market exclusivity and pricing power.
Changes in reimbursement policies, such as the introduction of value-based pricing models or inclusion in national formularies, also shape the commercial landscape.
Pricing Trends & Projections
Current Pricing Overview
As of [latest available quarter/year], the average wholesale price (AWP) of [drug name] is $X per unit/therapy course. Reimbursement rates vary across payer segments, with [Medicare, Medicaid, private insurers] adopting different coverage strategies.
In recent years, the drug’s list price has experienced an annual increase of X%, driven by [inflation, manufacturing costs, or market demand]. Notably, price reductions have occurred following [biosimilar entry, price negotiations, or policy changes].
Projected Price Trends (Next 5 Years)
Based on current trends and regulatory forecasts:
- Short-term (1-2 years): Prices are expected to stabilize or slightly increase (X% annually) due to [market stabilization, inflation, and demand].
- Medium-term (3-5 years): Introduction of biosimilars or generics could induce a price reduction of [estimated %], possibly leading to a new equilibrium in the $Y range.
- Long-term outlook: The drug’s price might decline by [X%] as market competition intensifies, but premium pricing for formulations with improved delivery or combined indications may sustain higher revenue streams.
The impact of healthcare policy reforms, including potential price negotiations by [government agencies], could accelerate downward pressure. Conversely, innovations extending patent life or enhancing efficacy could sustain higher prices.
Financial and Strategic Implications
Market penetration strategies, such as formulary inclusion and value-based contracts, will influence revenue streams. Approaches focusing on [patient access programs, co-pay assistance, or direct-to-consumer marketing] could expand opportunities.
Pricing strategies should consider payer negotiations, competitive pricing thresholds, and value propositions centered around [clinical benefits, reduced side effects, convenience]. Early engagement with payers and healthcare providers will be crucial to maximize reimbursement and market access.
Challenges & Risks
- Regulatory uncertainties: Pending approval of biosimilars or litigation outcomes may impact market exclusivity.
- Pricing pressures: Policy reforms aiming for drug price moderation could result in reimbursement constraints.
- Market dynamics: Emergence of alternative therapies, including novel modalities or personalized medicine approaches, could erode market share.
- Manufacturing costs: Supply chain disruptions or raw material costs influence pricing strategies.
Concluding Remarks
The outlook for [drug name] (NDC: 00113-0958) is characterized by an intricate balance of patent protection, competitive forces, and evolving healthcare policies. While near-term stability is probable, a long-term decline in prices due to increased competition, especially from biosimilars or generics, is anticipated. Strategic planning must focus on securing market access through value demonstration, regulatory engagement, and adaptive pricing models.
Key Takeaways
- The current market for [drug’s therapy area] exhibits steady growth, but pricing pressures are mounting due to biosimilar entry and policy reforms.
- Price projections suggest modest increases in the short term, with potential declines of [X%] projected over five years.
- Competitive differentiation hinges on efficacy, safety, and delivery innovations; aligning pricing strategies accordingly is imperative.
- Regulatory developments and patent expirations will significantly influence market exclusivity timelines and pricing power.
- Strategic engagement with payers and healthcare providers is critical to optimize reimbursement prospects amid evolving market conditions.
FAQs
-
What factors influence the price of NDY: 00113-0958 in the current market?
Market demand, competition (biosimilars/generics), regulatory status, manufacturing costs, and payer negotiation dynamics primarily shape its price. -
How will biosimilar entry affect the pricing of this drug?
Biosimilar competition typically leads to significant price reductions, reducing the original drug’s market share and revenue potential. -
Are there upcoming regulatory changes that could impact this drug's market?
Future policies favoring drug price negotiation, transparency, or biosimilar approvals may alter the market landscape and pricing strategies. -
What strategies can pharmaceutical companies adopt to maintain market share?
Companies should focus on demonstrating clinical value, forming early payer partnerships, and innovating in formulation or delivery to sustain premium pricing. -
How does the patent status influence future price projections?
Patent protections extending market exclusivity support higher prices; expirations typically trigger market entry of generics/biosimilars, leading to price declines.
References
- [1] IQVIA. Global Pharmaceutical Market Data. 2023.
- [2] FDA. Drug Approval and Patent Data. 2023.
- [3] EvaluatePharma. 2023 World Preview.
- [4] Centers for Medicare & Medicaid Services (CMS). Reimbursement and Policy Reports.
- [5] Industry Articles and Market Reports, 2023.
Note: Specific drug name, detailed market data, and certain projections require further exact data that can only be obtained via proprietary databases and current regulatory filings.
More… ↓
